Back to Journals

Journal of Blood Medicine


Call For Papers

Editor-in-Chief: Martin Bluth, MD, PhD

The Journal of Blood Medicine is indexed online:

  • Emerging Sources Citation Index (ESCI), from 2016
  • PubMed and PubMed Central (J Blood Med)
  • Scopus, from 2013 (Correct as at December 8, 2016)
  • Embase, from 2013 (Correct as at December 8, 2016)
  • Directory of Open Access Journals (DOAJ)
  • OAIster - The Open Access Initiative

Call for Papers: Thematic Series on “Clinical case reports on the alteration of hemostasis and their particular outcomes.”

Dove Medical Press is pleased to invite you to submit your work to an upcoming Thematic Series on “Clinical case reports on the alteration of hemostasis and their particular outcomes” guest edited by Dr Pierpaolo Di Micco in the Journal of Blood Medicine.

When submitting your work, please use the promo code ‘VOFME’ to indicate that your manuscript should be considered for the Thematic Series on “Clinical case reports on the alteration of hemostasis and their particular outcomes”. The deadline for submission of manuscripts is September 30th, 2019.

For any enquiries, please email to Amanda Sleeth, Commissioning Editor, at amandasleeth@dovepress.co.uk. 

About the Thematic Series

Bleeding disorders are characterized by defects in hemostasis. Recently much interest has arisen in the acute treatment of hemostatic diseases, due to the occasional occult nature of the symptomology and the limitations of the tests available. 

The journal Editors are seeking original research, case reports and review article submissions within

the theme of “Clinical case reports on the alteration of hemostasis and their particular outcomes”.

Papers addressing clinical experiences in diagnostic and therapeutic approaches of unique case reports in this field are welcomed, with a particular interest in the clinical variability of these pathologies to increase knowledge from not only a laboratory point of view but within clinical practice.

What is the advantage to you of publishing in the Journal of Blood Medicine?
  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
  • Unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. The Journal of Blood Medicine has a quicker turnaround time than this. Generally peer review is complete within 4-7 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 9 weeks for a final decision. 
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution a publication processing fee.

PubMed Central
The Journal of Blood Medicine is indexed on PubMed Central (title abbreviation: J Blood Med). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page, you'll just need to supply the working title of your next paper and when you intend to submit by.

Yours sincerely
Martin Bluth, MD, PhD
Editor-in-Chief
Journal of Blood Medicine

Email: Editor-in-Chief